Arrowstreet Capital’s Amryt Pharma plc American Depositary Shares AMYT Stock Holding History

Arrowstreet Capital’s Portfolio AMYT Stock Details AMYT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-64,483	Closed	-$940K	–	1553
2023 Q1	$940K	Buy	+64,483	New	+$911K	﹤0.01%	1078

Arrowstreet Capital's AMYT Position: Q2 2023 in Review

Arrowstreet Capital sold out of Amryt Pharma plc American Depositary Shares (AMYT) in Q2 2023, closing a stake of 64,483 shares — an estimated $940K sold.

Arrowstreet Capital first reported a position in AMYT in Q1 2023 and held it in 1 quarter. The position peaked at $940K in Q1 2023. 0 funds tracked by Wall St. Rank hold AMYT as of Q2 2023.

Arrowstreet Capital reported no remaining Amryt Pharma plc American Depositary Shares position as of Q2 2023 after selling out during the quarter.
Arrowstreet Capital sold 64,483 Amryt Pharma plc American Depositary Shares shares in Q2 2023, an estimated $940K.
Arrowstreet Capital first reported a position in Amryt Pharma plc American Depositary Shares in Q1 2023 and held it in 1 quarter.
Arrowstreet Capital's Amryt Pharma plc American Depositary Shares position peaked at $940K in Q1 2023.
0 funds tracked by Wall St. Rank held Amryt Pharma plc American Depositary Shares as of Q2 2023.

Based on Arrowstreet Capital's 13F filing for Q2 2023, filed 14 Aug 2023.